Researchers at the University of California, Davis have developed a novel nanotechnology platform that uses sealed mesoporous silica nanoreactors to accurately measure X-ray doses and dose enhancement factors in complex environments. These nanoreactors encapsulate chemical probe molecules inside sealed cavities, enabling precise, interference-free measurements even in the presence of catalysts, scavengers, or other reactive species.
Conventional X-ray dosimetry methods often fail in environments containing nanoparticles or radical scavengers because these external factors distort chemical probe reactions. This invention solves that problem by enclosing probe molecules within hollow mesoporous silica shells and sealing them with a protective layer. X-rays penetrate the shell, generating hydroxyl radicals inside the cavity, which react with the probes to produce fluorescent signals for dose measurement.
The technology provides a reliable, scalable, and versatile approach for fiducial X-ray dosimetry, enabling accurate measurements in environments where conventional methods fail. It also opens new possibilities for studying nanoscale energy deposition and chemical enhancement effects in X-ray nanochemistry, with potential applications in healthcare, materials science, and radiation safety.
| Country | Type | Number | Dated | Case |
| United States Of America | Published Application | 2021038218 | 12/09/2021 | 2019-095 |
dose enhancement, energy deposition, fiducial probe, mesoporous silica, nanochemistry, nanoreactor, radiation measurement, radiotherapy calibration, sealed nanoparticles, X-ray dosimetry